Retatrutide is a synthetic peptide designed to stimulate GLP-1, GIP and glucagon receptors simultaneously, a triple-agonist strategy under active investigation in metabolic and energy-balance research. Its multi-receptor profile lets researchers evaluate combined incretin and glucagon signaling effects on food intake, fat oxidation and glucose homeostasis in one molecule. The product arrives as a lyophilized white powder with >=99% HPLC purity in a sealed serum vial. Reconstitution guidance and lot-specific quality data are available, and bulk packaging can be arranged for multi-dose study programs. The peptide content is verified before release, and each batch is assigned a unique reference for traceability. Whether you need a single vial for a pilot experiment or kilograms for a long program, our production capacity and export experience can match the requirement with stable lead times.